373 related articles for article (PubMed ID: 10733530)
21. Dual control of myc expression through a single DNA binding site targeted by ets family proteins and E2F-1.
Roussel MF; Davis JN; Cleveland JL; Ghysdael J; Hiebert SW
Oncogene; 1994 Feb; 9(2):405-15. PubMed ID: 8290253
[TBL] [Abstract][Full Text] [Related]
22. Combination E2F-1 and p53 gene transfer does not enhance growth inhibition in human squamous cell carcinoma of the head and neck.
Frank DK; Liu TJ; Frederick MJ; Clayman GL
Clin Cancer Res; 1998 Sep; 4(9):2265-72. PubMed ID: 9748148
[TBL] [Abstract][Full Text] [Related]
23. E2F1 uses the ATM signaling pathway to induce p53 and Chk2 phosphorylation and apoptosis.
Powers JT; Hong S; Mayhew CN; Rogers PM; Knudsen ES; Johnson DG
Mol Cancer Res; 2004 Apr; 2(4):203-14. PubMed ID: 15140942
[TBL] [Abstract][Full Text] [Related]
24. ARF directly binds DP1: interaction with DP1 coincides with the G1 arrest function of ARF.
Datta A; Sen J; Hagen J; Korgaonkar CK; Caffrey M; Quelle DE; Hughes DE; Ackerson TJ; Costa RH; Raychaudhuri P
Mol Cell Biol; 2005 Sep; 25(18):8024-36. PubMed ID: 16135794
[TBL] [Abstract][Full Text] [Related]
25. Apoptosis-stimulating protein of p53-2 (ASPP2/53BP2L) is an E2F target gene.
Chen D; Padiernos E; Ding F; Lossos IS; Lopez CD
Cell Death Differ; 2005 Apr; 12(4):358-68. PubMed ID: 15592436
[TBL] [Abstract][Full Text] [Related]
26. PERP, a p53 proapoptotic target, mediates apoptotic cell death in renal ischemia.
Singaravelu K; Devalaraja-Narashimha K; Lastovica B; Padanilam BJ
Am J Physiol Renal Physiol; 2009 Apr; 296(4):F847-58. PubMed ID: 19158346
[TBL] [Abstract][Full Text] [Related]
27. Regulated ectopic expression of cyclin D1 induces transcriptional activation of the cdk inhibitor p21 gene without altering cell cycle progression.
Hiyama H; Iavarone A; LaBaer J; Reeves SA
Oncogene; 1997 May; 14(21):2533-42. PubMed ID: 9191053
[TBL] [Abstract][Full Text] [Related]
28. C/EBPbeta cooperates with RB:E2F to implement Ras(V12)-induced cellular senescence.
Sebastian T; Malik R; Thomas S; Sage J; Johnson PF
EMBO J; 2005 Sep; 24(18):3301-12. PubMed ID: 16107878
[TBL] [Abstract][Full Text] [Related]
29. Mechanisms of p53-mediated apoptosis.
Bates S; Vousden KH
Cell Mol Life Sci; 1999 Jan; 55(1):28-37. PubMed ID: 10065149
[TBL] [Abstract][Full Text] [Related]
30. A new component of the transcription factor DRTF1/E2F.
Girling R; Partridge JF; Bandara LR; Burden N; Totty NF; Hsuan JJ; La Thangue NB
Nature; 1993 Mar; 362(6415):83-7. PubMed ID: 8446173
[TBL] [Abstract][Full Text] [Related]
31. A new member of the DP family, DP-3, with distinct protein products suggests a regulatory role for alternative splicing in the cell cycle transcription factor DRTF1/E2F.
Ormondroyd E; de la Luna S; La Thangue NB
Oncogene; 1995 Oct; 11(8):1437-46. PubMed ID: 7478568
[TBL] [Abstract][Full Text] [Related]
32. PERP expression stabilizes active p53 via modulation of p53-MDM2 interaction in uveal melanoma cells.
Davies L; Spiller D; White MR; Grierson I; Paraoan L
Cell Death Dis; 2011 Mar; 2(3):e136. PubMed ID: 21451571
[TBL] [Abstract][Full Text] [Related]
33. Regulation of E2F-1 gene expression in avian cells.
Espanel X; Le Cam L; North S; Sardet C; Brun G; Gillet G
Oncogene; 1998 Aug; 17(5):585-94. PubMed ID: 9704924
[TBL] [Abstract][Full Text] [Related]
34. Adenoviral delivery of E2F-1 directs cell cycle reentry and p53-independent apoptosis in postmitotic adult myocardium in vivo.
Agah R; Kirshenbaum LA; Abdellatif M; Truong LD; Chakraborty S; Michael LH; Schneider MD
J Clin Invest; 1997 Dec; 100(11):2722-8. PubMed ID: 9389735
[TBL] [Abstract][Full Text] [Related]
35. Isolation of two novel cDNAs whose products associate with the amino terminus of the E2F1 transcription factor.
Jordan KL; Evans DL; Steelman S; Hall DJ
Biochemistry; 1996 Sep; 35(38):12320-8. PubMed ID: 8823166
[TBL] [Abstract][Full Text] [Related]
36. Structural characterization and specificity of expression of E2F-5: a new member of the E2F family of transcription factors.
Itoh A; Levinson SF; Morita T; Kourembanas S; Brody JS; Mitsialis SA
Cell Mol Biol Res; 1995; 41(3):147-54. PubMed ID: 8589754
[TBL] [Abstract][Full Text] [Related]
37. The p107 tumor suppressor induces stable E2F DNA binding to repress target promoters.
O'Connor RJ; Schaley JE; Feeney G; Hearing P
Oncogene; 2001 Apr; 20(15):1882-91. PubMed ID: 11313936
[TBL] [Abstract][Full Text] [Related]
38. Activation of ARF by oncogenic stress in mouse fibroblasts is independent of E2F1 and E2F2.
Palmero I; Murga M; Zubiaga A; Serrano M
Oncogene; 2002 May; 21(19):2939-47. PubMed ID: 12082524
[TBL] [Abstract][Full Text] [Related]
39. E2F-1 induces the stabilization of p53 but blocks p53-mediated transactivation.
Nip J; Strom DK; Eischen CM; Cleveland JL; Zambetti GP; Hiebert SW
Oncogene; 2001 Feb; 20(8):910-20. PubMed ID: 11314026
[TBL] [Abstract][Full Text] [Related]
40. Apaf-1 is a transcriptional target for E2F and p53.
Moroni MC; Hickman ES; Lazzerini Denchi E; Caprara G; Colli E; Cecconi F; Müller H; Helin K
Nat Cell Biol; 2001 Jun; 3(6):552-8. PubMed ID: 11389439
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
